Braftovi

Braftovi is a prescription medication used to treat patients with skin cancer, containing specific gene mutations, that cannot be surgically removed or has spread throughout the body. Braftovi is taken in combination with another medication called binimetinib (brand name Mektovi).

Braftovi belongs to a group of drugs called kinase inhibitors, which are used in targeting many cancers. Kinases are enzymes that change how proteins work. By targeting BRAF and MEK kinases, Braftovi taken in combination with Mektovi helps to inhibit overactive signals that cause melanoma cells to grow out of control.

This medication comes in capsule form and is taken once a day, with or without food.

Common side effects include tiredness, nausea and vomiting. Braftovi can also cause dizziness. Do not drive or operate heavy machinery until you know how Braftovi affects you.